Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board denied the veteran's claims for increased initial disability ratings and effective dates, as well as remanded a claim for entitlement to TDIU.

The veteran withdrew all pending claims and appeals, resulting in the dismissal of the appeal.

The Board denied service connection for visual impairment and remanded the claims for cervical strain, eczema, and lumbosacral strain.

The Board granted an initial rating of 10 percent for dermatitis, effective January 8, 2025.

The appeal for service connection for sleep apnea was dismissed due to untimeliness, while the claims for a skin disability and stomach disability were remanded for further examination.

The Veteran's eczema with a history of atopic dermatitis is rated as 60 percent disabling, and he has been granted a total disability rating based on individual unemployability due to his service-connected disabilities.

The Board remands the claims for further development due to pre-decisional duty to assist errors, including unconfirmed service locations and lack of VA examinations.

The Board granted service connection for an acquired psychiatric disorder and a respiratory condition, but denied service connection for chloracne. The Veteran's bladder cancer was rated at the maximum schedular rating of 100 percent, and an earlier effective date for DEA benefits was also denied.

The Board granted service connection for tinea pedis and bilateral foot arthritis, but denied service connection for diabetes mellitus type II. For the increase rating period from July 22, 2022, a maximum 60 percent rating for tinea versicolor was granted.

The Board dismissed the appeals for service connection and increased rating due to improper concurrent election of review options.

The appeals for an initial compensable rating for pseudofolliculitis barbae and service connection for residuals of tonsil removal have been withdrawn by the Veteran's attorney.

The Board remands the claims for service connection for a skin disorder, basal cell carcinoma of the left breast, and menorrhagia to correct duty to assist errors.

The Board denied service connection for bilateral hearing loss, a higher rating for migraine headaches, and a compensable rating for tinea corporis of the left elbow.

The Board granted a separate 60 percent rating for venous disease in the left lower extremity and a separate 40 percent rating for venous disease in the right lower extremity, but denied an initial rating in excess of 10 percent for statis dermatitis.

The Board remands the claims for further development, including obtaining a complete set of service treatment records and scheduling additional VA examinations.

The Board remands the claims for an initial compensable rating for seborrheic dermatitis, service connection for hypertension, and service connection for dry eyes to obtain additional evidence.

The Board denied service connection for benign prostatic hyperplasia and overflow incontinence, exhaustion, and dermatitis as the evidence did not show a causal relationship between these conditions and the Veteran's active-duty service, including exposure to contaminated water at Camp Lejeune.

The Board denied service connection for bilateral hearing loss, obstructive sleep apnea, posttraumatic stress disorder (PTSD), and right and left knee disabilities. However, the claim for an earlier effective date of December 30, 2022, for pseudofolliculitis barbae with dermatitis was granted.

The Board denied a compensable rating for vitamin deficiency and a disability rating in excess of 30 percent for pseudofolliculitis barbae (PFB) based on the evidence of record.

The Board remands the claims for a rating in excess of 70 percent for PTSD with TBI, a rating in excess of 10 percent for contact dermatitis, and whether the reduction from 30 percent to zero percent for migraine headaches was proper. The claim for TDIU is also remanded.